{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T19:39:17Z","timestamp":1783021157832,"version":"3.54.6"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences Inc","doi-asserted-by":"publisher","award":["CO-TW-380-5446"],"award-info":[{"award-number":["CO-TW-380-5446"]}],"id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ijid.2025.108284","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T08:10:36Z","timestamp":1764922236000},"page":"108284","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Efficacy of same-day initiation of antiretroviral therapy with coformulated bictegravir, emtricitabine, and tenofovir alafenamide: Week 48 results of a single-arm, open-label, multicenter clinical trial"],"prefix":"10.1016","volume":"163","author":[{"given":"Yi-Chia","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Chien","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsin-Yun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Hsing","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Hsi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Jui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Jen","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Ping","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo-Huang","family":"Liou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Ti","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Liang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7345-0836","authenticated-orcid":false,"given":"Chien-Ching","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2025.108284_sbref0001","series-title":"HIV statistics, globally and by WHO region, 2025","year":"2025"},{"key":"10.1016\/j.ijid.2025.108284_bib0002","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1001\/jama.2018.1818","article-title":"Effect of offering same-day ART vs usual health facility referral during home-based HIV testing on linkage to care and viral suppression among adults with HIV in Lesotho: the CASCADE randomized clinical Trial","volume":"319","author":"Labhardt","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.ijid.2025.108284_bib0003","article-title":"Initiating antiretroviral therapy for HIV at a patient\u2019s first clinic visit: the RapIT randomized controlled trial","volume":"13","author":"Rosen","year":"2016","journal-title":"PLoS Med"},{"key":"10.1016\/j.ijid.2025.108284_bib0004","doi-asserted-by":"crossref","first-page":"92","DOI":"10.11604\/pamj.2023.46.92.40848","article-title":"Same-day ART initiation, loss to follow-up and viral load suppression among people living with HIV in low- and middle-income countries: systematic review and meta-analysis","volume":"46","author":"Bakari","year":"2023","journal-title":"Pan Afr Med J"},{"key":"10.1016\/j.ijid.2025.108284_bib0005","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1093\/cid\/ciad317","article-title":"Treatment outcomes after offering same-day initiation of HIV treatment\u2014how to interpret discrepancies between different studies?","volume":"77","author":"Labhardt","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2025.108284_bib0006","unstructured":"Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in adults and adolescents with HIV. Department of Health and Human Services; 2024. Available from: https:\/\/clinicalinfo.hiv.gov\/en\/guidelines\/adult-and-adolescent-arv [accessed 15 May 2024]."},{"key":"10.1016\/j.ijid.2025.108284_sbref0007","series-title":"EACS guidelines version 12.0","year":"2023"},{"key":"10.1016\/j.ijid.2025.108284_bib0008","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/jac\/dkad008","article-title":"Same-day initiation of bictegravir\/emtricitabine\/tenofovir alafenamide: week 48 results of the FAST study-IMEA 055","volume":"78","author":"Bachelard","year":"2023","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2025.108284_bib0009","doi-asserted-by":"crossref","first-page":"ofad101","DOI":"10.1093\/ofid\/ofad101","article-title":"Sustained virologic suppression with dolutegravir\/lamivudine in a test-and-treat setting through 48 weeks","volume":"10","author":"Rolle","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ijid.2025.108284_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2024.107164","article-title":"Bictegravir\/emtricitabine\/tenofovir alafenamide as first-line treatment in na\u00efve HIV patients in a rapid-initiation model of care: BIC-NOW clinical trial","volume":"63","author":"Hidalgo-Tenorio","year":"2024","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijid.2025.108284_bib0011","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.26419","article-title":"Early initiation of fast-track care for persons living with HIV initiating dolutegravir-based regimens during a period of severe civil unrest in Port-au-Prince, Haiti: a pilot randomized trial","volume":"28","author":"Marc","year":"2025","journal-title":"J Int AIDS Soc"},{"key":"10.1016\/j.ijid.2025.108284_bib0012","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jmii.2024.11.003","article-title":"Forty years of HIV infection and AIDS in Taiwan: reflection on the past and looking toward the future","volume":"58","author":"Huang","year":"2025","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.ijid.2025.108284_sbref0013","series-title":"The role of HIV viral suppression in improving individual health and reducing transmission: policy brief","year":"2023"},{"key":"10.1016\/j.ijid.2025.108284_sbref0014","series-title":"Statistics for human immunodeficiency virus (HIV) infection, nationwide, citizen and non-citizen, date of diagnosis","year":"2025"},{"key":"10.1016\/j.ijid.2025.108284_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijid.2023.12.012","article-title":"Comparable clinical outcomes with same-day versus rapid initiation of antiretroviral therapy in Taiwan","volume":"140","author":"Huang","year":"2024","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijid.2025.108284_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.jiph.2025.102677","article-title":"Impact of same-day ART initiation on medical care and medication discontinuation among patients with incident HIV infection or AIDS in Taiwan: a population-based cohort study","volume":"18","author":"Chueh","year":"2025","journal-title":"J Infect Public Health"},{"key":"10.1016\/j.ijid.2025.108284_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2023.107049","article-title":"Rapid ART initiation with bictegravir\/emtricitabine\/tenofovir alafenamide in individuals presenting with advanced HIV disease (Rainbow study)","volume":"63","author":"Camici","year":"2024","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijid.2025.108284_bib0017","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S0140-6736(23)00877-2","article-title":"The risk of sexual transmission of HIV in individuals with low-level HIV viraemia: a systematic review","volume":"402","author":"Broyles","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2025.108284_bib0018","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/cid\/ciae012","volume":"79","author":"Wang","year":"2024","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2025.108284_bib0019","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1007\/s44197-024-00329-y","article-title":"Antiretroviral treatment adherence among people living with HIV in Taipei, Taiwan","volume":"14","author":"Lai","year":"2024","journal-title":"J Epidemiol Glob Health"},{"key":"10.1016\/j.ijid.2025.108284_bib0020","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1097\/QAD.0000000000002979","article-title":"Dolutegravir\/lamivudine as a first-line regimen in a test-and-treat setting for newly diagnosed people living with HIV","volume":"35","author":"Rolle","year":"2021","journal-title":"AIDS"},{"key":"10.1016\/j.ijid.2025.108284_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.101991","article-title":"Bictegravir\/emtricitabine\/tenofovir alafenamide as initial treatment for HIV-1: five-year follow-up from two randomized trials","volume":"59","author":"Sax","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.ijid.2025.108284_bib0022","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.jmii.2024.07.003","article-title":"Twelve-month effectiveness and safety of bictegravir\/emtricitabine\/tenofovir alafenamide in treatment-na\u00efve and treatment-experienced people with HIV: findings from the Asia cohort of the BICSTaR study","volume":"57","author":"Tseng","year":"2024","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.ijid.2025.108284_bib0023","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.3390\/jcm10163456","article-title":"Do all integrase strand transfer inhibitors have the same lipid profile? Review of randomised controlled trials in na\u00efve and switch scenarios in HIV-infected patients","volume":"10","author":"Saumoy","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.ijid.2025.108284_bib0024","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1093\/cid\/ciz999","article-title":"Weight gain following initiation of antiretroviral therapy: risk factors in randomized comparative clinical trials","volume":"71","author":"Sax","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2025.108284_bib0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003226","article-title":"A clinical algorithm for same-day HIV treatment initiation in settings with high TB symptom prevalence in South Africa: the SLATE II individually randomized clinical trial","volume":"17","author":"Maskew","year":"2020","journal-title":"PLoS Med"},{"key":"10.1016\/j.ijid.2025.108284_bib0026","first-page":"203","article-title":"Health behavior survey and community center to promote health in men who have sex with men","volume":"32","author":"Liu","year":"2016","journal-title":"Taiwan Epidemiol Bull"},{"key":"10.1016\/j.ijid.2025.108284_bib0027","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.25897","article-title":"Towards the first 90: impact of the national HIV self-test program on case finding and factors associated with linkage to confirmatory diagnosis in Taiwan","volume":"25","author":"Huang","year":"2022","journal-title":"J Int AIDS Soc"},{"key":"10.1016\/j.ijid.2025.108284_bib0028","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.jmii.2023.08.015","article-title":"Assessment of the performance regarding confirmatory diagnosis and initiation of antiretroviral therapy under a modified national HIV testing algorithm and pay-for-performance program in Taiwan","volume":"56","author":"Huang","year":"2023","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.ijid.2025.108284_bib0029","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s40121-022-00734-5","article-title":"Comparison of virological efficacy of DTG\/ABC\/3TG and B\/F\/TAF regimens and discontinuation patterns in persons living with advanced HIV in the era of rapid ART: a retrospective multicenter cohort study","volume":"12","author":"Lee","year":"2023","journal-title":"Infect Dis Ther"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971225005065?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971225005065?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T18:52:03Z","timestamp":1783018323000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971225005065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":30,"alternative-id":["S1201971225005065"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2025.108284","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of same-day initiation of antiretroviral therapy with coformulated bictegravir, emtricitabine, and tenofovir alafenamide: Week 48 results of a single-arm, open-label, multicenter clinical trial","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2025.108284","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"108284"}}